Schizophrenia Clinical Trials

Find Schizophrenia Clinical Trials Near You

Sensory Contributions to Third Visual Pathway Dysfunction in Schizophrenia: Correlation and Causation

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study investigates the ability of transcranial direct current stimulation (tDCS) applied over the motion processing area of the brain (area MT) to improve face emotion recognition (FER) ability. tDCS is a type of non-invasive brain stimulation in which low level currents are applied over the scalp to influence underlying brain function. In schizophrenia, impaired ability to detect facial motion has been shown to contribute to impaired FER, which, in turn, leads to difficulties in social cognition and poor social outcome. The study will use both fMRI and EEG to measure brain function while participants view moving dot and dynamic face stimuli. Analyses will compare changes in fMRI and EEG activity in individuals receiving active vs. sham stimulation.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 55
Healthy Volunteers: f
View:

• Male or female subject, age 18-55

• Competent and willing to sign informed consent

• No more than moderately ill

• SCID DSM-5 diagnosis of Sz/SzAff

• WAIS IQ \>70

• Does not meet current criteria for DSM-5 defined substance abuse or dependence or have a history of diagnosis within past 6 months

• On medication within clinically approved range

• Does not meet criteria for another DSM-5 disorder other than those judged to be minor (e.g. simple phobia)

Locations
United States
New York
Nathan Kline Institute
RECRUITING
Orangeburg
Contact Information
Primary
Odeta Beggel, MA
odeta.beggel@nki.rfmh.org
845-398-2897
Time Frame
Start Date: 2026-02-01
Estimated Completion Date: 2030-07
Participants
Target number of participants: 120
Treatments
Experimental: Active tDCS
Personalized, high-definition tDCS applied to area MT+
Sham_comparator: Sham tDCS
Sham tDCS applied over area MT+, using ramp up/ramp down to simulate active treatment
Related Therapeutic Areas
Sponsors
Collaborators: Columbia University, Research Foundation for Mental Hygiene, Inc., National Institute of Mental Health (NIMH)
Leads: Nathan Kline Institute for Psychiatric Research

This content was sourced from clinicaltrials.gov